非小细胞肺癌术后辅助化疗研究进展

肺癌可分为非小细胞肺癌（non-small cell lung cancer, NSCLC）和小细胞肺癌，其发病率和死亡率均高居恶性肿瘤首位。本文主要就NSCLC术后辅助化疗的地位确立、辅助化疗的合适人群和化疗方案选择以及相关生物标志物研究进展作一综述。...

Full description

Saved in:
Bibliographic Details
Published in中国肺癌杂志 Vol. 17; no. 6; pp. 501 - 505
Main Author 韩娜 卢红阳
Format Journal Article
LanguageChinese
Published 310022 杭州，浙江省肿瘤医院，浙江省胸部肿瘤 肺 食管 诊治技术研究重点实验室 2014
Subjects
化学治疗
肺肿瘤
辅助治疗
辅助治疗
Chemotherapy
肺肿瘤
化学治疗
Adjuvant therapy
Lung neoplasms
Online AccessGet full text
ISSN1009-3419
1999-6187
DOI10.3779/j.issn.1009-3419.2014.06.12

Cover

More Information
Summary:肺癌可分为非小细胞肺癌（non-small cell lung cancer, NSCLC）和小细胞肺癌，其发病率和死亡率均高居恶性肿瘤首位。本文主要就NSCLC术后辅助化疗的地位确立、辅助化疗的合适人群和化疗方案选择以及相关生物标志物研究进展作一综述。
Bibliography:Na HAN, Hongyang LU （Zhejiang Cancer Hospital, Zhejiang Key Laboratory of Diagnosis and Treatment Technology on Thoracic Oncology （Lung and Esoph- agus）, Hangzhou 310022, China）
Lung cancer including non-small cell lung cancer （NSCLC） and SCLC is the most commonly diagnosed cancer and leading cause of cancer-related death worldwide. hTis review focuses on progress of the effect, indications, regimens and the related biological markers of postoperative adjuvant chemotherapy in NSCLC.
Lung neoplasms; Adjuvant therapy; Chemotherapy
12-1395/R
ISSN:1009-3419
1999-6187
DOI:10.3779/j.issn.1009-3419.2014.06.12